Literature DB >> 28480193

Opposite effects of Agrimonia pilosa Ledeb aqueous extracts on blood coagulation function.

Xianming Fei1, Wufeng Yuan1, Lei Jiang1, Huan Wang1.   

Abstract

BACKGROUND: Agrimonia pilosa Ledeb (APL) has showed anticoagulant and antithrombotic activities in some studies, whereas its actual effects on blood coagulation are still unclear. This study was designed to observe the in vitro effects of APL aqueous extracts on blood coagulation, as well as to investigate the underlying mechanisms.
METHODS: Studies were divided into four groups: 0, 4, 20, and 80 g/L of APL aqueous extracts mixed with plasma or whole blood samples. Clotting time of whole blood, plasma coagulation tests, activities of plasma coagulation factors, plasma calcium ion, platelet aggregation test, and platelet fibrinogen receptor as well as the blood viscosity were measured.
RESULTS: It was observed that the APL aqueous extracts in 4 g/L significantly prolonged the whole blood clotting time and activated partial thromboplastin time, shortened prothrombin time, decreased activities of coagulation factor VIII, IX and XI, and levels of platelet aggregation and fibrinogen receptor expression. However, coagulation factor VII activity, and blood viscosity were increased after the extracts treatment. And the effects of APL extracts were in a concentration-dependent manner (0-80 g/L).
CONCLUSIONS: The results suggest that APL aqueous extracts have a total anticoagulant activity, whereas they exhibit opposite effects of greater anticoagulant activity than pro-coagulant activity.

Entities:  

Keywords:  Agrimonia pilosa Ledeb; anticoagulant activity; aqueous extracts; procoagulant activity

Year:  2017        PMID: 28480193      PMCID: PMC5401677          DOI: 10.21037/atm.2017.03.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  22 in total

1.  Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution.

Authors:  Jorge W Ojito; Robert L Hannan; Michelle Moore Burgos; Hyunsoo Lim; Monique Huynh; Evelio Velis; Marino Arocha; Christopher F Tirotta; Redmond P Burke
Journal:  J Extra Corpor Technol       Date:  2012-03

2.  Shortened activated partial thromboplastin time: causes and management.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Luigi Ippolito; Massimo Franchini; Emmanuel J Favaloro
Journal:  Blood Coagul Fibrinolysis       Date:  2010-07       Impact factor: 1.276

3.  Evaluation of the automated coagulation analyzer Sysmex CA-7000.

Authors:  Florence Fischer; Anny Appert-Flory; Didier Jambou; Pierre Toulon
Journal:  Thromb Res       Date:  2005-08-10       Impact factor: 3.944

Review 4.  Intrinsic pathway of coagulation and arterial thrombosis.

Authors:  David Gailani; Thomas Renné
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-04       Impact factor: 8.311

Review 5.  Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.

Authors:  Alisa S Wolberg; Maria M Aleman; Karin Leiderman; Kellie R Machlus
Journal:  Anesth Analg       Date:  2011-11-21       Impact factor: 5.108

6.  Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.

Authors:  Nina A Guzzetta; Heather G Monitz; Janet D Fernandez; Tom M Fazlollah; Andrea Knezevic; Bruce E Miller
Journal:  Anesth Analg       Date:  2010-06-02       Impact factor: 5.108

7.  The effects of aminoglycoside antibiotics on platelet aggregation and blood coagulation.

Authors:  Guoqiang Chen; Xianming Fei; Jie Ling
Journal:  Clin Appl Thromb Hemost       Date:  2012-02-12       Impact factor: 2.389

8.  Does calcium cause the different effects of Gelofusine and Haemaccel on coagulation?

Authors:  T J Coats; M Heron
Journal:  Emerg Med J       Date:  2006-03       Impact factor: 2.740

9.  Are hemostasis and thrombosis two sides of the same coin?

Authors:  Robert W Colman
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

10.  An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking Clopidogrel.

Authors:  Seung-Jae Joo; Joon-Hyouk Choi; Song-Yi Kim; Ki-Seok Kim; Young Ree Kim; Sung Ha Kang
Journal:  Korean Circ J       Date:  2015-05-08       Impact factor: 3.243

View more
  3 in total

Review 1.  The therapeutic effects of Agrimonia eupatoria L.

Authors:  Z Paluch; L Biriczová; G Pallag; E Carvalheiro Marques; N Vargová; E Kmoníčková
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

2.  Network Pharmacology-Based Combined with Experimental Validation Study to Explore the Underlying Mechanism of Agrimonia pilosa Ledeb. Extract in Treating Acute Myocardial Infarction.

Authors:  Muqing Zhang; Jian Chen; Yanwei Wang; Guobin Kang; Yixin Zhang; Xue Han
Journal:  Drug Des Devel Ther       Date:  2022-09-15       Impact factor: 4.319

3.  Proteomics Analysis of Antitumor Activity of Agrimonia pilosa Ledeb. in Human Oral Squamous Cell Carcinoma Cells.

Authors:  Tae-Young Kim; Kwang-Soo Koh; Ji-Min Ju; Yeon-Ju Kwak; Soo-Kyung Bae; Hye-Ock Jang; Da-Sol Kim
Journal:  Curr Issues Mol Biol       Date:  2022-07-25       Impact factor: 2.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.